Price went up $50 this month with no warning - switching vendors — 6 month update

Answering the narrow version, because the broad one does not have a single answer. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

DanielChem_CHI said:

Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion.

Right, and one flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.

claudia_zurich said:

The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…

Agreed, with a caveat about community reputation: it is a lagging indicator. Reports arrive weeks after orders, so a supplier can look excellent for a month after quality has already changed.

That is the short version; the long version is somebody else's post.

Clinical perspective, offered as context rather than as advice.

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

1. Prior authorization appeal with peer-to-peer review
2. Manufacturer copay card (for commercial insurance)
3. Patient assistance programs (Novo Nordisk, Eli Lilly)
4. Compounded medication from a 503B pharmacy ($134/month)
5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.